BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

Résultats de recherche: Contribution à un journal/une revueArticle de revue

langue originaleAnglais
Pages (de - à)e68-e88
journalTH Open
Volume02
Numéro de publication1
Les DOIs
étatPublié - 2018

Citer ceci

@article{66a27f13c8b24ae3ad3cff556782919b,
title = "BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?",
keywords = "BCR-ABL, arterial thrombotic events, tyrosine kinase inhibators, chronic myeloid leukemia",
author = "H{\'e}l{\`e}ne Haguet and Jonathan Douxfils and Christian Chatelain and Carlos Graux and Fran{\cc}ois Mullier and Jean-Michel Dogne",
year = "2018",
doi = "DOI: 10.1055/s-0038-1624566",
language = "English",
volume = "02",
pages = "e68--e88",
journal = "TH Open",
issn = "2512-9465",
publisher = "Thieme Medical Publishers",
number = "1",

}

BCR-ABL Tyrosine Kinase Inhibitors : Which Mechanism(s) May Explain the Risk of Thrombosis? / Haguet, Hélène; Douxfils, Jonathan; Chatelain, Christian; Graux, Carlos; Mullier, François; Dogne, Jean-Michel.

Dans: TH Open, Vol 02, Numéro 1, 2018, p. e68-e88.

Résultats de recherche: Contribution à un journal/une revueArticle de revue

TY - JOUR

T1 - BCR-ABL Tyrosine Kinase Inhibitors

T2 - Which Mechanism(s) May Explain the Risk of Thrombosis?

AU - Haguet, Hélène

AU - Douxfils, Jonathan

AU - Chatelain, Christian

AU - Graux, Carlos

AU - Mullier, François

AU - Dogne, Jean-Michel

PY - 2018

Y1 - 2018

KW - BCR-ABL

KW - arterial thrombotic events

KW - tyrosine kinase inhibators

KW - chronic myeloid leukemia

U2 - DOI: 10.1055/s-0038-1624566

DO - DOI: 10.1055/s-0038-1624566

M3 - Review article

VL - 02

SP - e68-e88

JO - TH Open

JF - TH Open

SN - 2512-9465

IS - 1

ER -